Abstract Both the neuropeptide Y (NPY) and the leptin systems have been shown to be important central mediators of bone metabolism. However, the interaction between these two systems is complex and not fully understood. Here, we show that a unique interaction exists between Y2 and Y4 receptors in the regulation of bone homeostasis that is not evident when combined with lack of Y1 signalling. Despite the hypoleptinaemia shown in male Y2/Y4 double knockout (Y2
Introduction
The understanding of the important role that neuronal signals play in the regulation of skeletal tissue has increased markedly in recent years following the identification of several powerful, centrally mediated pathways linking the brain to the control of bone mass, through the modulation of osteoblast activity. One such example involves neuropeptide Y (NPY)-mediated signalling through Y2 receptors expressed in neurons of the hypothalamus (Baldock et al. 2002) . A second pathway involves leptin signalling via its hypothalamic receptor (Ducy et al. 2000) to β2 adrenergic receptors in the osteoblast (Takeda et al. 2002) . Y2 and leptin receptors are co-expressed on NPY neurons in the arcuate nucleus and have been shown to interact in mediating leptin's effects on energy homeostasis (Baskin et al. 1999) ; however, their relationship in the control of bone mass is uncertain. Studies in the leptin-deficient state have returned conflicting results. Y2 receptor and leptin-deficient double mutant mice (Y2 −/− ;ob/ob) displayed no additive effect on cancellous bone volume or osteoblast activity, suggesting the two pathways may share certain common elements in the control of bone homeostasis (Baldock et al. 2005) . However, a subsequent study provided clear evidence that independent actions also exist, as greater cortical bone formation was observed in Y2 −/− ;ob/ob compared to ob/ob mice, while bone resorption was elevated in the leptin-deficient models but was unchanged in Y2 −/− mice (Baldock et al. 2006 ). Adding to this complexity, as circulating leptin levels increase, the independence of the two pathways becomes more apparent. Particularly at normal or elevated leptin levels, the lack of Y2 receptor signalling induces a clear increase in bone formation compared to Y2 intact controls (Baldock et al. 2005) .
The source of this varied interaction between the NPY and leptin pathways may relate, in part, to the complexity of the NPY system. Superficially, NPY's effect on bone reveals a relatively simple inverse relationship. Mice deficient in NPY display enhanced bone mass in both the cancellous and cortical compartments due to increased osteoblast activity whilst viralmediated overexpression of NPY specifically in the hypothalamus of mice leads to decreased bone mass and osteoblast activity, despite markedly increased body weight and adiposity ). However, NPY is known to act through at least five different Y receptors, which have varied and widespread expression. Studies using germline knockout mice have revealed a definitive role for both Y1 and Y2 receptors in the regulation of bone mass. Whilst Y2 receptors act in the hypothalamus to inhibit osteoblast activity (Baldock et al. 2002) , Y1 receptors inhibit bone metabolism via direct actions on bone cells (Baldock et al. 2007; Lee et al. 2010) . Furthermore, no additive effect on bone mass was observed with deletion of both Y1 and Y2 receptors, suggesting that they may act at different points along the same pathway with respect to the control of bone formation (Baldock et al. 2007 ).
However, the role of Y receptors in the regulation of bone mass is more complex. Y2 receptors have been shown to be inhibitory autoreceptors (Zhang et al. 1997) . Thus, the loss of Y2 receptors increases NPY production in the hypothalamus, a change even more apparent in double Y2 and Y4 knockout (Y2 −/− Y4 −/− ) mice (Sainsbury et al. 2003) . This increased NPY expression in the arcuate nucleus of the hypothalamus would be expected to decrease bone formation, but bone formation is in fact increased in Y2 −/− mice and even more so in Y2 −/− Y4 −/− mice (Sainsbury et al. 2003) . The mechanism behind this seeming contradiction is unclear. Whilst the deletion of Y4 receptors had no obvious effect on bone homeostasis in mice (Sainsbury et al. 2003) , the combined deletion of both Y2 and Y4 receptors produced a further increase in bone compared to Y2 −/− mice (Sainsbury et al. 2003) . Interestingly, this synergism was evident only in male Y2 −/− Y4 −/− mice and was coincident with a gender-specific lean phenotype and a threefold decrease in serum leptin (Sainsbury et al. 2003) . Leptin deficiency is associated with increased cancellous bone volume (Ducy et al. 2000) but reduced cortical bone mass (Baldock et al. 2006) . Similarly, the Y2 −/− Y4 −/− -mediated reduction in circulating leptin levels was coincident with an increase in cancellous bone volume and a decrease in cortical bone mass compared to normoleptinaemic Y2 −/− mice (Sainsbury et al. 2003) . Moreover, an effect of combined Y2 and Y4 receptor deficiency on femoral bone mineral density and bone mineral content was also evident in both male and female ob/ob mice (Lee et al. 2008a Subsequently, the interaction with leptin signalling was investigated by the deletion of various Y receptor combinations in the absence of leptin using ob/ob mice and in the presence of excess leptin by employing viral-mediated overexpression of NPY in the hypothalamus.
Materials and Methods

Generation of Germline Y Receptor Knockout Mice
Germline deletion of Y1, Y2 and Y4 receptor genes was achieved as previously described (Sainsbury et al. 2002a, b; Howell et al. 2003 
Virus Injections
Adult mice were anaesthetised with a single dose of ketamine/ xylazine (100 mg/kg and 20 mg/kg; ip) and injected with adenoassociated virus (AAV) expressing either NPY or an empty vector control as previously described (Lin et al. 2006 ).
Tissue Collection and Analysis
Mice were injected with calcein (20 mg/kg) 10 and 3 days prior to tissue collection and killed by cervical dislocation at 16 weeks of age. Femurs and tibias were excised, fixed overnight in 4% paraformaldehyde in phosphate-buffered saline at 4°C and then stored in 70% ethanol at 4°C before undergoing processing.
Bone Densitometry Analysis
Whole body bone mineral density and bone mineral content were measured in anaesthetised mice using a dedicated mouse dual X-ray absorbitometry (DXA) (Lunar Piximus II, GE Medical Systems, Madison, WI, USA) 3 days prior to tissue collection. In addition, excised individual femora and tibiae were scanned following collection, fixation and removal of soft tissue.
Histomorphometry
Following fixation, the right femora were bisected transversely at the midpoint of the shaft, and the distal halves embedded and undecalcified in methyl-methacrylate (APS Chemicals, Sydney, Australia). Five-micrometre sagittal sections were analysed as previously described (Baldock et al. 2002) . Briefly, cancellous bone volume (BV/TV, percent), trabecular number (number/millimetre) and trabecular thickness (micrometre) were calculated from von Kossa-stained sections whilst osteoclast surface (percent) was used to estimate bone resorption from sections stained for tartrate-resistant acid phosphatase activity. Mineral apposition rate (MAR, micrometre/day) was used to estimate bone formation from unstained sections. All analysis was carried out using Leica QWin analysis software (Leica Microsystems Ltd., Heerberg, Switzerland).
Statistical Analyses
All data are expressed as means±SEM. Differences between groups were assessed by ANOVA, followed by Tukey's post hoc tests if an overall significance was detected by ANOVA. Statistical analyses were performed with SPSS for Mac OS X, version 17.0 (SPSS Inc., Chicago, IL, USA). For all statistical analyses, p<0.05 was accepted as being statistically significant. 2003, 2006) , although this was more pronounced in the Y2 −/− Y4 −/− mice which also showed decreased serum leptin levels. Importantly, however, serum levels of corticosterone, free T4, glucose, testosterone and insulin-like growth factor-1 were all similar between groups and were not different from wild-type levels . In male mice, all Y receptor models investigated displayed elevated cancellous bone volume, although it failed to reach statistical significance in the Y1 (Fig. 1a ).
Results
Greater Elevation of Cancellous
This increase in bone volume was associated with significantly increased trabecular thickness (Fig. 1c) and mineral apposition rate (Fig. 1d ) compared to wild-type mice. In addition, the greatest elevation in cancellous bone volume was evident in male Y2
−/− Y4 −/− double knockout mice (Fig. 1a ).
This marked increase in cancellous bone volume in male Y2
−/− Y4 −/− mice was associated with greater trabecular number ( Fig. 1b) and mineral apposition rate (Fig. 1d ) compared with wild-type and other double and triple knockout mice investigated. However, no interaction was evident in any of the other models investigated where cancellous bone volume and mineral apposition rate were increased only to levels similar to that previously shown in single Y1 −/− and Y2 −/− mice (Baldock et al. 2002 (Baldock et al. , 2007 .
Interestingly, the marked effects of double Y2 and Y4 receptor deletion on cancellous bone volume (Fig. 1a) , trabecular number (Fig. 1b) and osteoblast activity (Fig. 1d) were no longer evident when combined with Y1 receptor deletion.
In female mice, cancellous bone volume was similarly elevated in all Y receptor-deficient models compared to control, with no differences between models (Fig. 1a) . This increase was associated with enhanced bone formation as demonstrated by significantly increased mineral apposition rate in all models compared to wild-type (Fig. 1d) . Despite 
the lack of a greater effect in female Y2
−/− Y4 −/− mice compared to other knockout models studied, the elevated cancellous bone volume in female Y2
−/− Y4 −/− mice was associated with increased trabecular number (Fig. 1b) whereas in the other Y receptor-deficient models it was associated with increased trabecular thickness (Fig. 1c) . Interestingly, bone resorption was also elevated in both male and female double Y2 −/−
Y4
−/− knockout mice as demonstrated by significantly increased osteoclast surface compared to wild-type and other Y receptor-deficient models investigated (Fig. 1e) . Again, this effect was no longer evident when combined with Y1 receptor deletion. Thus, these data reveal a unique interaction between Y1, Y2 and Y4 receptor signalling in both the osteoblastic and osteoclastic regulation of cancellous bone mass, albeit one that is more pronounced in male animals.
Combined Lack of Y2, Y4 and Leptin Signalling Does not Increase Cancellous Bone Mass
The data presented above suggest a unique skeletal response to combined Y2 and Y4 receptor deletion (in the absence of Y1 deficiency) resulting in enhanced cancellous bone mass. Previous studies also identified a reduction in cortical bone mass in these mice (Sainsbury et al. 2003) . This opposing response between the two bone envelopes is consistent with the skeletal effects of hypoleptinaemia known to be present in male Y2 −/− Y4 −/− mice (Sainsbury et al. 2003) . To examine the dependence of the Y2 
Y4
−/− mice were crossed onto the leptindeficient, ob/ob background. In contrast to findings in leptin-intact models above (Fig. 1) , in the complete absence of leptin, cancellous bone volume was not greater in Y2
−/− Y4 −/− mice than in other models (Fig. 2a) , nor was trabecular thickness or trabecular number (data not shown). Moreover, the levels of cancellous bone volume in leptindeficient models was not greater than that shown in leptinintact models in Fig. 1a . Interestingly, the cancellous bone volume of Y2 −/− Y4 −/− ; ob/ob mice was not significantly different to wild-type levels (Fig. 2a) , suggesting that the unique increase in cancellous bone volume and osteoblast activity in male Y2 (Fig. 1 ) may not involve a direct response to hypoleptinaemia. However, it does still indicate the potential for unique signalling to bone in the absence of both Y2 and Y4 receptors. Conversely, cortical bone mass of Y2
;ob/ob mice was decreased, as indicated by long bone length, known to be reduced in ob/ob mice (Hamrick et al. 2004) , which was further reduced following the additional loss of both Y2 and Y4 receptor signalling in both male and female mice (Fig. 2b) . This is in addition to previously described significant reductions in femoral bone mineral density and bone mineral content in both sexes of Y2
;ob/ob mice compared to wild-type, even in the absence of correction for The cortical effects of leptin deficiency seen in ob/ob mice, which act in opposition to cancellous changes, have been postulated to result from the elevated hypothalamic NPY levels resulting from loss of leptin signalling (Lee et al. 2008b) . Thus, the greater cortical changes evident in Y2
;ob/ob mice may represent an enhanced response to hypothalamic NPY signalling rather than a generalised effect of leptin deficiency. Moreover, the reduced cancellous bone seen in Y2 Baldock et al. 2005) . However, tibial bone mineral density (Fig. 3a) and bone mineral content (Fig. 3b) were reduced to significantly lower levels in Y2
to the other genotypes investigated, despite equivalent NPY expression (data not shown). Indeed, the percentage change in both tibial bone mineral density and tibial bone mineral content in NPY-treated mice compared to empty control was two-to threefold greater in Y2 −/− Y4 −/− mice than other genotypes (Fig. 3c) , indicating the existence of a unique response pattern in these mice which is no longer apparent when combined with Y1 receptor deletion. It is interesting to note that these decreases in bone mass following NPY overproduction occurred despite marked (50-70%) increases in body weight (Lin et al. 2006) . That bone mass increases consistently with body weight is one of the most fundamental relationships in skeletal biology (Reid 2008) . Thus, the loss of bone following NPY overproduction is evidence of the power of the antiosteogenic pathway induced by central NPY signalling. As with skeletal changes, body weight changes were attenuated between Y2 −/−
−/− and Y1
further indicating the importance of Y1 receptor signalling in the absence of Y2 and Y4 receptors (Lin et al. 2006) . We next investigated whether the unique skeletal effect of elevated hypothalamic NPY in Y2 −/− Y4 −/− mice is also evident in cancellous bone. As shown in Fig. 4 , increased central NPY expression did not alter cancellous bone volume, trabecular thickness or trabecular number in wildtype mice. However, it did abolish the elevated cancellous bone volume (Fig. 4a ) and trabecular thickness (Fig. 4b ) evident in all Y receptor knockout models investigated. Together, these data show that combined Y2 and Y4 receptor deletion in mice leads to an enhanced response to central NPY levels in both cortical and cancellous bone. Interestingly, the additional deletion of the Y1 receptor eliminates this unique response.
Discussion
Results from this study help to delineate the complex interaction between the NPY and the leptin systems on bone homeostasis. In particular, we show that the unique interaction between Y2 and Y4 receptors is not seen with other Y receptor combinations such as Y1/Y2 double knockout as well as Y1/Y4 double knockout. Importantly, these data also demonstrate that the major effects of Y2 and Y4 deletion on bone are lost when combined with Y1 receptor deletion. Furthermore, the combined lack of Y2 and Y4 receptor signalling reduces the potent effect of leptin deficiency to promote cancellous bone mass whilst exacerbating the effect of leptin deficiency to decrease cortical bone. This phenotype is consistent with an exaggerated response to the anti-osteogenic actions of increased hypothalamic NPY that is secondary to the loss of leptin as demonstrated by the extreme loss of both cancellous and cortical bone shown in Y2 −/−
Y4
−/− mice with viral overexpression of hypothalamic NPY. The NPY-mediated regulation of bone mass has been shown to involve signalling via central Y2 receptors (Baldock et al. 2002) and osteoblastic Y1 receptors (Lee et al. 2010) . In contrast, the Y4 receptor and its primary ligand pancreatic polypeptide (PP) do not appear to play a role in bone (Sainsbury et al. 2003; Wortley et al. 2007 ). However, the unique skeletal changes in Y2
−/− mice present an opportunity to examine the system more closely: in particular, the interaction between NPY and leptindeficient regulation of bone mass. Hypoleptinaemic male Y2
−/− Y4 −/− mice display a unique increase in cancellous bone volume coincident with reduced cortical bone mass (Sainsbury et al. 2003) . This phenotype was not present with any other combination of Y receptor deletion investigated and suggests an interaction between the NPYdeficient ) and β2 adrenergic-deficient (Takeda et al. 2002) regulation of osteoblast activity, as evident in NPY knockout and leptin-deficient ob/ob mice, respectively. Previous studies examining crosses of either Y1 or Y2 receptor null mice with leptin-deficient models have failed to identify additive effects in cancellous bone, whilst activities were opposing in cortical bone (Baldock et al. 2005 (Baldock et al. , 2006 Allison et al. 2009 ). In contrast to these previously published models, the Y2 −/− Y4 −/− ;ob/ob mice showed a generalised reduction of bone mass in both cortical and cancellous bone. Such a phenotype is consistent with an exaggerated response to the anti-osteogenic actions of increased hypothalamic NPY that is secondary to the loss of leptin (Wilding et al. 1993) . Indeed, in addition to the exaggerated loss of cortical bone (Lee et al. 2008a) 
−/− mice, a locus-specific elevation in NPY expression was induced in mature mice, using a virally mediated approach. This method has the advantage of minimising developmental changes associated with leptin deficiency. Increased NPY expression in the arcuate nucleus has been shown to induce marked antiosteogenic activities in bone (Baldock et al. 2005) and results were consistent with previous studies. However, Y2
−/− Y4 −/− mice again displayed a unique response, with markedly greater reductions in both cancellous and cortical bone mass, despite equivalent increases in NPY. In this manner, the mechanism responsible for the unique skeletal response can be isolated to the hypothalamus and further to signalling involving arcuate NPY. Importantly, the exaggerated response to arcuate NPY was again normalised in Y1 edly increased anti-osteogenic responses to NPY injection that were corrected by loss of Y1. These interrelationships between the receptors of the NPY system and their effects upon peripheral tissue homeostasis represent an important consideration in the development of potential therapeutic agents. In addition to consideration of the receptor specificity of any such agent, the compensatory response by those remaining receptors must also be evaluated.
